<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02155010</url>
  </required_header>
  <id_info>
    <org_study_id>2014-003</org_study_id>
    <nct_id>NCT02155010</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine in Spinal Anesthesia</brief_title>
  <official_title>Hemodynamic Effect of Dexmedetomidine on Heavy Bupivacaine Spinal Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inje University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients were randomized into two groups, A group and B group. A group and B group patients
      are injected intravenous dexmedetomidine after intrathecal injection (IT) of heavy
      bupivacaine and injected intravenous dexmedetomidine before IT of heavy bupivacaine,
      respectively.

      The investigators will compare of hemodynamics and patient's comfortability between two
      groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A and B group patients will intravenous inject dexmedetomidine 1mcg/kg for 10 minute loading
      infusion and 0.2mcg/kg/hr for continuous infusion. A group receive intravenous
      dexmedetomidine after procedure, and B group receive intravenous dexmedetomidine before
      procedure. Both group patients will hydrate 6 ml/kg crystalloid solution and will evaluated
      patient's anxiety and comfortability perioperative period. Vital signs will record 5 minutes
      interval at operating room and post-anesthetic care units.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Hypotension</measure>
    <time_frame>up to 3 hours</time_frame>
    <description>We compare incidence rate of hypotension during infusion of dexmedetomidine</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient's Anxiety</measure>
    <time_frame>up to 3 days</time_frame>
    <description>We compared patient's anxiety using spielberger's state-trait anxiety inventory before and after surgery. This consists of two self-evaluation scales designed to assess state-anxiety and trait-anxiety. Each scale contains 20 items, each of which is rated from 1 to 4. Clinically significant levels of state or trait-anxiety were defined as scores &gt;50 on the state- or trait-anxiety scale. State or trait-anxiety inventory's minimal score is 20 and maximal score is 80. We analyzed State Anxiety Inventory scale before and after surgery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">74</enrollment>
  <condition>Blood Pressure</condition>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IV dexmedetomidine infusion before intrathecal injection of heavy bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine with heavy bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IV dexmedetomidine infusion after intrathecal injection of heavy bupivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Dexmedetomidine infusion before intrathecal injection of heavy bupivacaine</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine with heavy bupivacaine</intervention_name>
    <description>Dexmedetomidine infusion after IT of heavy bupivacaine</description>
    <arm_group_label>Dexmedetomidine with heavy bupivacaine</arm_group_label>
    <other_name>Precedex</other_name>
    <other_name>Marcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  20 - 60 aged patients

          -  orthopedic operation undergoing spinal anesthesia

        Exclusion Criteria:

          -  more than American society of anesthesiologists classification 3

          -  hypertension

          -  diabetes mellitus

          -  heart disease (bradycardia, atrioventricular block)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ki Hwa Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Inje University, Haeundae paik hospital</name>
      <address>
        <city>Busan</city>
        <zip>612-896</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2014</study_first_submitted>
  <study_first_submitted_qc>June 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2014</study_first_posted>
  <results_first_submitted>December 10, 2015</results_first_submitted>
  <results_first_submitted_qc>August 3, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 26, 2016</results_first_posted>
  <last_update_submitted>August 3, 2016</last_update_submitted>
  <last_update_submitted_qc>August 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inje University</investigator_affiliation>
    <investigator_full_name>Ki Hwa Lee</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Spinal anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified individual participant data for all primary and secondary outcome measures will be made available within 3 years of study completion.</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Dexmedetomidine Before Bupivacaine</title>
          <description>IV dexmedetomidine infusion before intrathecal injection of heavy bupivacaine
Dexmedetomidine: Dexmedetomidine infusion before intrathecal injection of heavy bupivacaine</description>
        </group>
        <group group_id="P2">
          <title>Dexmedetomidine After Bupivacaine</title>
          <description>IV dexmedetomidine infusion after intrathecal injection of heavy bupivacaine
Dexmedetomidine with heavy bupivacaine: Dexmedetomidine infusion after IT of heavy bupivacaine</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Before Spinal Anesthesia</title>
          <description>IV dexmedetomidine infusion before intrathecal injection of heavy bupivacaine
Dexmedetomidine: Dexmedetomidine infusion before intrathecal injection of heavy bupivacaine</description>
        </group>
        <group group_id="B2">
          <title>After Spinal Anesthesia</title>
          <description>IV dexmedetomidine infusion after intrathecal injection of heavy bupivacaine
Dexmedetomidine with heavy bupivacaine: Dexmedetomidine infusion after IT of heavy bupivacaine</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="31"/>
            <count group_id="B2" value="31"/>
            <count group_id="B3" value="62"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.74" spread="12.27"/>
                    <measurement group_id="B2" value="35.87" spread="11.22"/>
                    <measurement group_id="B3" value="37.31" spread="11.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Incidence of Hypotension</title>
        <description>We compare incidence rate of hypotension during infusion of dexmedetomidine</description>
        <time_frame>up to 3 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Before Spinal Anesthesia</title>
            <description>IV dexmedetomidine infusion before intrathecal injection of heavy bupivacaine
Dexmedetomidine: Dexmedetomidine infusion before intrathecal injection of heavy bupivacaine</description>
          </group>
          <group group_id="O2">
            <title>After Spinal Anesthesia</title>
            <description>IV dexmedetomidine infusion after intrathecal injection of heavy bupivacaine
Dexmedetomidine with heavy bupivacaine: Dexmedetomidine infusion after IT of heavy bupivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Hypotension</title>
          <description>We compare incidence rate of hypotension during infusion of dexmedetomidine</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient's Anxiety</title>
        <description>We compared patient's anxiety using spielberger's state-trait anxiety inventory before and after surgery. This consists of two self-evaluation scales designed to assess state-anxiety and trait-anxiety. Each scale contains 20 items, each of which is rated from 1 to 4. Clinically significant levels of state or trait-anxiety were defined as scores &gt;50 on the state- or trait-anxiety scale. State or trait-anxiety inventory's minimal score is 20 and maximal score is 80. We analyzed State Anxiety Inventory scale before and after surgery.</description>
        <time_frame>up to 3 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Before Spinal Anesthesia</title>
            <description>IV dexmedetomidine infusion before intrathecal injection of heavy bupivacaine
Dexmedetomidine: Dexmedetomidine infusion before intrathecal injection of heavy bupivacaine</description>
          </group>
          <group group_id="O2">
            <title>After Spinal Anesthesia</title>
            <description>IV dexmedetomidine infusion after intrathecal injection of heavy bupivacaine
Dexmedetomidine with heavy bupivacaine: Dexmedetomidine infusion after IT of heavy bupivacaine</description>
          </group>
        </group_list>
        <measure>
          <title>Patient's Anxiety</title>
          <description>We compared patient's anxiety using spielberger's state-trait anxiety inventory before and after surgery. This consists of two self-evaluation scales designed to assess state-anxiety and trait-anxiety. Each scale contains 20 items, each of which is rated from 1 to 4. Clinically significant levels of state or trait-anxiety were defined as scores &gt;50 on the state- or trait-anxiety scale. State or trait-anxiety inventory's minimal score is 20 and maximal score is 80. We analyzed State Anxiety Inventory scale before and after surgery.</description>
          <units>points</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>State Anxiety Inventory (Preoperative)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.65" spread="14.24"/>
                    <measurement group_id="O2" value="45.52" spread="12.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>State Anxiety Inventory (discharge from PACU)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.03" spread="10.51"/>
                    <measurement group_id="O2" value="38.55" spread="8.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>State Anxiety Inventory (postoperative first day)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.90" spread="9.03"/>
                    <measurement group_id="O2" value="34.55" spread="8.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>&lt;24 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Before Spinal Anesthesia</title>
          <description>IV dexmedetomidine infusion before intrathecal injection of heavy bupivacaine
Dexmedetomidine: Dexmedetomidine infusion before intrathecal injection of heavy bupivacaine</description>
        </group>
        <group group_id="E2">
          <title>After Spinal Anesthesia</title>
          <description>IV dexmedetomidine infusion after intrathecal injection of heavy bupivacaine
Dexmedetomidine with heavy bupivacaine: Dexmedetomidine infusion after IT of heavy bupivacaine</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>We did not assess the differences among the groups regarding postoperative analgesic consumption and the duration of sensory or motor bloakade produced by spinal anesthesia with dexmedetomidine infusion.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Ki Hwa Lee</name_or_title>
      <organization>Haeundae paik hospital, Inje University</organization>
      <phone>82-51-797-0421</phone>
      <email>tedy3333@naver.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

